Tender Details

Country: USA
Summary: Notice of Intent to SoleSource for Pluvicto Lutetium Lu 177 Vipivotide Tetraxetan for Buffalo VA Medical Center
UST Ref No: 127794349
Deadline: 20 Oct 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 36C24226Q0049
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions.
The Network Contracting Office (NCO) 2, Department of Veterans Affairs intends to award a firm-fixed-price sole source contract with Novartis Pharmaceuticals Corporation, a large business, for the purchase of 9 units of Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan) for
VA Western New York Healthcare System
Buffalo VA Medical Center
Nuclear Medicine
3495 Bailey Avenue
Buffalo, NY 14215
This sole source determination is in accordance with FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. Advanced Accelerator Applications USA, Inc. is the only known authorized supplier for Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan).
The North American Industry Classification System (NAICS) code for this procurement is 325412, Pharmaceutical Preparation Manufacturing. The Federal Supply Class (FSC) is 6505, Drugs and Biologicals. The Small Business Administration (SBA) size standard for this sector is 1,300 Employees.
Statement of Need: The New York/New Jersey Healthcare System Veterans Integrated Service Network (VISN) 2, in support of VA Buffalo Medical Center has a requirement for 9 units of Pluvicto (Lutetium Lu 177 Vipivotide Tetraxeta...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Notice of Intent to SoleSource for Pluvicto Lutetium Lu 177 Vipivotide Tetraxetan for Buffalo VA Medical Center - USA Tender

The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Notice of Intent to SoleSource for Pluvicto Lutetium Lu 177 Vipivotide Tetraxetan for Buffalo VA Medical Center. This tender is published on USARFP under UST Ref No: 127794349 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-20.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.